https://www.selleckchem.com/pr....oducts/gsk2879552-2h
dequately powered double-blinded parallel design. The remaining statements are presented as potential additional considerations. Discussion This article summarizes the areas discussed and presents Consensus Statements to guide development of future clinical trials of LT4/LT3 combination therapy. The results of such redesigned trials are expected to be of benefit to patients and of value to inform future thyroid hormone replacement clinical practice guidelines treatment recommendations.This is the story of a career in theoretical
Like
Comment
Share
